Hydrochloric Acid → (1R,2S)-5'-methoxy-2-(3-(4-(1-methylpiperidin-4-yl)phenyl)-1H-indazol-6-yl)spiro[cyclopropane-1,3'-indolin]-2'-one hydrochloride

HRID 1466373Notizen

Reaktionsgleichung

Reaktionsgleichung von HRID 1466373
IC1C2C(=CC([C@H]3[C@@]4(C5C(=CC=C(OC)C=5)NC4=O)C3)=CC=2)NN=1.CN1CCC(C2C=CC(B3OC(C)(C)C(C)(C)O3)=CC=2)CC1.[ClH:47].[CH3:48][O:49][C:50]1[CH:51]=[C:52]2[C:56](=[CH:57][CH:58]=1)[NH:55][C:54](=[O:59])[C@:53]12[CH2:61][C@H:60]1[C:62]1[CH:70]=[C:69]2[C:65]([C:66]([C:71]3[CH:76]=[CH:75][C:74]([CH:77]4[CH2:82][CH2:81][N:80]([CH3:83])[CH2:79][CH2:78]4)=[CH:73][CH:72]=3)=[N:67][NH:68]2)=[CH:64][CH:63]=1>CCOC(C)=O.O.C1COCC1>[ClH:47].[CH3:48][O:49][C:50]1[CH:51]=[C:52]2[C:56](=[CH:57][CH:58]=1)[NH:55][C:54](=[O:59])[C@:53]12[CH2:61][C@H:60]1[C:62]1[CH:70]=[C:69]2[C:65]([C:66]([C:71]3[CH:76]=[CH:75][C:74]([CH:77]4[CH2:82][CH2:81][N:80]([CH3:83])[CH2:79][CH2:78]4)=[CH:73][CH:72]=3)=[N:67][NH:68]2)=[CH:64][CH:63]=1

Komponenten

8

Edukt 4

HCID 313Hydrochloric AcidHCID 584862351-Methyl-4-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)piperidineHCID 58486259US9907800, Example A123HCID 178487035HCID 178487035, Verbindung

Produkt 1

HCID 67449499(1R,2S)-5'-methoxy-2-(3-(4-(1-methylpiperidin-4-yl)phenyl)-1H-indazol-6-yl)spiro[cyclopropane-1,3'-indolin]-2'-one hydrochlorideAusbeute 17 %

Reagenzien, Katalysatoren, Lösungsmittel 3

HCID 962WaterLösungsmittelHCID 8028TetrahydrofuranLösungsmittelHCID 8857Ethyl AcetateLösungsmittel

Versuchsvorschrift

The title compound was synthesized according to the method of Example A51B, except reacting (1R,2S)-2-(3-iodo-1H-indazol-6-yl)-5′-methoxyspiro[cyclopropane-1,3′-indolin]-2′-one (195 mg, 0.45 mmol) with 1-methyl-4-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)piperidine (150 mg, 0.50 mmol). The reaction was then allowed to cool to rt and was diluted with EtOAc and water was added. The resulting mixture was extracted with EtOAc and the combined organic extracts were washed with brine, dried over MgSO4 and concentrated to give an orange solid. The title compound was purified by silica gel chromatography (95:3:2 to 80:18:2 CH2Cl2/MeOH/NH3) to yield a yellow solid. HCl (1M in diethyl ether, 0.15 mL, 0.15 mmol) was added in a dropwise manner to a solution of (1R,2S)-5′-methoxy-2-(3-(4-(1-methylpiperidin-4-yl)phenyl)-1H-indazol-6-yl)spiro[cyclopropane-1,3′-indolin]-2′-one in THF (2 mL). A brown precipitate formed and the solid was then filtered and freeze-dried to give the title compound as a white solid (43 mg, 17%). 1H NMR (400 MHz, CD3OD) δ 7.95-7.92 (m, 3H), 7.52 (s, 1H), 7.44 (d, J=8.0 Hz, 2H), 7.05 (d, J=8.5 Hz, 1H), 6.83 (d, J=8.1 Hz, 1H), 6.62 (d, J=8.7 Hz, 1H), 5.61 (s, 1H), 3.67-3.64 (m, 2H),), 3.40-3.32 (m, 1H), 3.27 (s, 3H), 3.21 (t, J=12.8 Hz, 2H), 3.04-2.93 (m, 1H), 2.96 (s, 3H), 2.28-2.19 (m, 4H), 2.07-1.98 (m, 2H); MS ESI 479.4 [M+H]+, calcd for [C30H30N4O2+H]+ 479.24.

Aufarbeitung

  1. customThe title compound was synthesized
  2. additionwas added
  3. extractionThe resulting mixture was extracted with EtOAc
  4. washthe combined organic extracts were washed with brine
  5. dry with materialdried over MgSO4
  6. concentrationconcentrated
  7. customto give an orange solid
  8. customThe title compound was purified by silica gel chromatography (95:3:2 to 80:18:2 CH2Cl2/MeOH/NH3)
  9. customto yield a yellow solid
  10. customA brown precipitate formed
  11. filtrationthe solid was then filtered
  12. customfreeze-dried

Quellen und Nachweise

ORD-Eintrag
ord-1904402f2bf84e029ab46c9e8f4de436
Quelldatensatz
uspto-grants-2015_04
Patentnummer
US08999968B2

Notizen zur Reaktion

Wird geladen…